Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Increased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patients

Fig. 3

Expression of α-defensin and HNP 1–3. a α-Defensin mRNA expression (2-fold changes) relative to β-actin mRNA in PBMCs obtained from healthy controls, and hyperlipidemia and CHD patients post graft bypass surgery, as determined by qRT-PCR. Data are presented as the mean 2-fold change relative to control ± SEM (n = 10). b Plasma levels of HNP 1–3 (pg/ml) from healthy controls, hyperlipidemia patients and CHD patients post graft bypass surgery. Data are presented as mean ± SEM (n = 17). One-way ANOVA followed by Scheffe’s post hoc test for statistical significance of mRNA expression and HNP levels (p < 0.05) were used for statistical comparisons

Back to article page